ES8609351A1 - Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico. - Google Patents
Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico.Info
- Publication number
- ES8609351A1 ES8609351A1 ES547625A ES547625A ES8609351A1 ES 8609351 A1 ES8609351 A1 ES 8609351A1 ES 547625 A ES547625 A ES 547625A ES 547625 A ES547625 A ES 547625A ES 8609351 A1 ES8609351 A1 ES 8609351A1
- Authority
- ES
- Spain
- Prior art keywords
- hydrosoluble
- pharmaceutical compositions
- antibiotic pharmaceutical
- antibiotic
- salified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003115 biocidal effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS HIDROSOLUBLES A BASE DE SALES DEL ACIDO (-)CIS-1,2-EPOXIPROPILFOSFONICO. COMPRENDE: A) HACER REACCIONAR EL ACIDO (-)CIS-1,2-EPOXIPROPILFOSFONICO CON UN AMINOACIDO TAL COMO ARGININA, ORNITINA, LISINA O CISTEINA, PARA ASI FORMAR LA SAL DE AMINOACIDO DE FOSFOMICINA; Y B) TRATAR LA SAL FORMADA EN LA ETAPA ANTERIOR CON UN EXCESO DE UN AMINOACIDO NO SALIFICADO QUE PUEDE SER IGUAL O DIFERENTE A LOS ANTERIORES, ENCONTRANDOSE EL AMINOACIDO EN EXCESO EN UNA RELACION MOLAR QUE OSCILA ENTRE 0,4 Y 0,8. TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIBIOTICA, PUDIENDO SER ADMINISTRADOS POR VIA PARENTERAL U OTRAS FORMAS DE SOLUCION.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH4792/84A CH660306A5 (de) | 1984-10-05 | 1984-10-05 | Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES547625A0 ES547625A0 (es) | 1986-09-01 |
| ES8609351A1 true ES8609351A1 (es) | 1986-09-01 |
Family
ID=4282621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES547625A Expired ES8609351A1 (es) | 1984-10-05 | 1985-10-04 | Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico. |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS62223121A (es) |
| KR (1) | KR860003012A (es) |
| AT (1) | AT383736B (es) |
| BE (1) | BE903369A (es) |
| CH (1) | CH660306A5 (es) |
| DE (1) | DE3535356A1 (es) |
| ES (1) | ES8609351A1 (es) |
| FR (1) | FR2571255B1 (es) |
| GB (1) | GB2165152B (es) |
| IT (1) | IT1201479B (es) |
| NL (1) | NL8502712A (es) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH310498A (de) * | 1951-11-14 | 1955-10-31 | Waldhof Zellstoff Fab | Verfahren zur Stabilisierung von Alkalisalzen von Adenosinpolyphosphorsäuren. |
| GB1195612A (en) * | 1967-04-13 | 1970-06-17 | Sumitomo Chemical Co | An Injection |
| US3639590A (en) * | 1967-07-25 | 1972-02-01 | Merck & Co Inc | Antibacterial composition containing (-) (cis-1 2-epoxypropyl) phosphoric acid |
| BE756953A (fr) * | 1969-10-02 | 1971-04-01 | Merck & Co Inc | Potentialisation d'antibiotiques |
| IT1161974B (it) * | 1978-02-02 | 1987-03-18 | Italchemi Spa | Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono |
| DE2813814A1 (de) * | 1978-03-31 | 1979-10-18 | Boehringer Mannheim Gmbh | Hochwirksame, enteral resorbierbare pharmazeutische praeparate |
| IT1112282B (it) * | 1978-07-19 | 1986-01-13 | Zambon Spa | Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato |
| IT1097578B (it) * | 1978-07-31 | 1985-08-31 | Italchemi Spa | Metodo per la preparazione di sali dell'acido (-) |
| US4235900A (en) * | 1978-11-15 | 1980-11-25 | E. R. Squibb & Sons, Inc. | Cephradine compositions |
-
1984
- 1984-10-05 CH CH4792/84A patent/CH660306A5/de not_active IP Right Cessation
-
1985
- 1985-10-02 JP JP60219969A patent/JPS62223121A/ja active Pending
- 1985-10-03 DE DE19853535356 patent/DE3535356A1/de not_active Withdrawn
- 1985-10-03 AT AT0287185A patent/AT383736B/de not_active IP Right Cessation
- 1985-10-04 ES ES547625A patent/ES8609351A1/es not_active Expired
- 1985-10-04 BE BE2/60807A patent/BE903369A/nl not_active IP Right Cessation
- 1985-10-04 GB GB08524550A patent/GB2165152B/en not_active Expired
- 1985-10-04 IT IT22367/85A patent/IT1201479B/it active
- 1985-10-04 NL NL8502712A patent/NL8502712A/nl not_active Application Discontinuation
- 1985-10-05 KR KR1019850007328A patent/KR860003012A/ko not_active IP Right Cessation
- 1985-10-07 FR FR8514800A patent/FR2571255B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3535356A1 (de) | 1986-04-24 |
| IT8522367A0 (it) | 1985-10-04 |
| ATA287185A (de) | 1987-01-15 |
| ES547625A0 (es) | 1986-09-01 |
| FR2571255A1 (fr) | 1986-04-11 |
| AT383736B (de) | 1987-08-10 |
| BE903369A (nl) | 1986-02-03 |
| IT1201479B (it) | 1989-02-02 |
| NL8502712A (nl) | 1986-05-01 |
| JPS62223121A (ja) | 1987-10-01 |
| CH660306A5 (de) | 1987-04-15 |
| GB2165152A (en) | 1986-04-09 |
| GB2165152B (en) | 1988-03-16 |
| KR860003012A (ko) | 1986-05-19 |
| FR2571255B1 (fr) | 1988-09-16 |
| GB8524550D0 (en) | 1985-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8801930A1 (es) | Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino | |
| HK1008054A1 (en) | Homogeneous mammalian hematopoietic stem cell composition | |
| IE45390L (en) | Anti-caries composition | |
| JPS52116465A (en) | Peptides | |
| AU532114B2 (en) | Salts of n-substituted-2-pyrrolidone-4-carboxylic acids | |
| ES2014060A6 (es) | Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular. | |
| CA2015186A1 (en) | Nutrient composition | |
| GB2181647B (en) | Compositions based on lysine and arginine salts. | |
| ATE63750T1 (de) | Peptid, dessen herstellung und benutzung. | |
| JPS5486635A (en) | First liquid of cold-wave lotion | |
| ES8407011A1 (es) | Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c. | |
| ES8609351A1 (es) | Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico. | |
| MY101821A (en) | Quinazolinediones and pyridopyrimidinediones | |
| ES8608861A1 (es) | Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina. | |
| GB1051686A (es) | ||
| AU544742B2 (en) | Prepare amides especially peptides | |
| ES8308305A1 (es) | Procedimiento para la preparacion de un peptido. | |
| JPS6463342A (en) | Stabilization of glutathione-containing composition | |
| ES8703847A1 (es) | Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina | |
| ES2000182A6 (es) | Procedimiento para la obtencion de (iso) ureas substituidas potenciadoras del rendimiento. | |
| ES8606259A1 (es) | Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo. | |
| ES8308832A1 (es) | Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina. | |
| ES2001042A6 (es) | Un metodo para la preparacion de acidos 5,6-dialcoxiantranilicos | |
| ES8705847A1 (es) | Procedimiento para preparar nuevos derivados de n-(2-hidro- xialquil)-aminoacidos | |
| ES476430A1 (es) | Procedimiento para preparar antibioticos de tipo peptido de cadena recta |